MedTrace Logo

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

NCT05167058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2023-10-03

No results posted yet for this study

Summary

The SWAF study will compare the performance of a smartwatch combined with Cardiologs Platform algorithm in the detection of Atrial Fibrillation and other arrhythmias with that measured on a manually read 12-lead ECG in subjects hospitalized for cardioversion or AF ablation.

Conditions

  • Atrial Fibrillation
  • Tachycardia
  • Bradycardia
  • Premature Supraventricular Beat
  • Premature Ventricular Contraction

Interventions

DEVICE

Cardiologs Platform

Smartwatch recordings interpreted by Cardiologs AI done simultaneously with each 12-lead ECG

Sponsors & Collaborators

  • Cardiologs Technologies

    lead INDUSTRY

Principal Investigators

  • Elaine Y Wan, MD · Columbia University, New York

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2023-01-20
Completion
2023-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05167058 on ClinicalTrials.gov